SEC FilingsForm 8-KIOVANCE BIOTHERAPEUTICS, INC. filed this Form 8-K on 10/12/2018Document OutlineEntire Document (293.6 KB)Subdocument 1 - 8-K - FORM 8-KPage 1 - UNITED STATESPage 2 - Forward-Looking StatementsPage 3 - EXHIBITPage 4 - SIGNATURESSubdocument 2 - EX-1.1 - EXHIBIT 1.1Page 1 - Exhibit 1.1Page 2 - Exchange Act ) that is or is deemed to be incorporated by reference in the Registration Statement, tPage 3 - N/APage 4 - N/APage 5 - N/APage 6 - N/APage 7 - N/APage 8 - N/APage 9 - N/APage 10 - N/APage 11 - N/APage 12 - N/APage 13 - Section 2. Purchase, Sale and Delivery of the Offered Shares.Page 14 - N/APage 15 - Section 3. Additional Covenants of the Company.Page 16 - N/APage 17 - N/APage 18 - N/APage 19 - N/APage 20 - Section 4. Payment of Expenses. The Company agrees to pay all costs, fees and expenses incurred in cPage 21 - N/APage 22 - Section 7. Reimbursement of Underwriters Expenses. If this Agreement is terminated by the RepresentaPage 23 - Section 8. Effectiveness of this Agreement. This Agreement shall become effective upon the executionPage 24 - N/APage 25 - Section 10. Contribution. If the indemnification provided for in Section 9 is for any reason held toPage 26 - Section 11. Default of One or More of the Several Underwriters. If, on the First Closing Date or anyPage 27 - Underwriter shall be deemed to include any person substituted for a defaulting Underwriter under thiPage 28 - Section 15. Notices. All communications hereunder shall be in writing and shall be mailed, hand deliPage 29 - Section 18. Governing Law Provisions. This Agreement shall be governed by and construed in accordancPage 30 - JEFFERIES LLCPage 31 - Schedule APage 32 - Exhibit APage 33 - Exhibit BPage 34 - Exhibit CPage 35 - N/APage 36 - N/APage 37 - N/APage 38 - N/APage 39 - Exhibit DSubdocument 3 - EX-5.1 - EXHIBIT 5.1Page 1 - N/ASubdocument 4 - EX-99.1 - EXHIBIT 99.1Page 1 - Exhibit 99.1Page 2 - About Iovance Biotherapeutics, Inc.Subdocument 5 - EX-99.2 - EXHIBIT 99.2Page 1 - Exhibit 99.2Page 2 - About Iovance Biotherapeutics, Inc.Page 3 - Investor Relations Contact:
